Artemis Diagnostics Announces Company Name Change To Lightpoint Medical, And Appointment Of David Ford To The Board Of Directors
RICKMANSWORTH, England, January 25, 2013 /PRNewswire/ --
Artemis Diagnostics Ltd, a developer of innovative imaging technologies for cancer surgery, announced today that the company has changed its name to Lightpoint Medical Ltd. The name change reflects the company's focus on the medical device sector.
The company also announced the appointment of David Ford to its Board of Directors. Mr Ford has more than 20 years' experience in the medical device industry including 12 years at board level. Formerly the Executive Director of BSI Group, he was responsible for the worldwide Healthcare and Testing activity for the British Standards Institution. During David's tenure, BSI became the leading certification and accreditation body to the global healthcare industry incorporating two notified bodies in support of the European Medical Devices Directive. David is currently a Non-Executive Director at TrusTECH, an innovation gateway within the NHS. He has represented the United Kingdom at the World Health Organization, the FDA and the European Commission in developing policy for medical devices and medical device regulation. David was trained at St. Mary's Hospital Medical School, London and at Brunel University, and holds an MBA from INSEAD.
Dr David Tuch, CEO of Lightpoint Medical, commented "We are delighted to welcome David Ford to our Board of Directors. David's extensive experience in medical device regulations, marketing, and sales will bring significant value to Lightpoint Medical. We look forward to his contributions to the company as we advance our imaging technology to the market."About Lightpoint Medical Lightpoint Medical is an early-stage medical device company seeking to improve health outcomes for cancer patients through image-guided surgery. The company's molecular imaging technology, based on Cerenkov Luminescence Imaging, has the potential to detect cancer in real-time during surgery, providing more accurate cancer treatment while sparing healthy tissue. For more information contact David Tuch on +44-(0)7725-832-539, email@example.com or visit http://www.lightpointmedical.com. SOURCE Lightpoint Medical
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV